Default company panoramic image
Ae03dd63 b034 43da b8db 6f66d3a4f153

Woodland Pharmaceuticals

Drug-resistant cell models for oncology screening and xenograft studies. (Drug resistance and tumor recurrence is what kills people.)

  • Stage Product In Development
  • Industry Biotechnology
  • Location Worcester, MA, USA
  • Currency USD
  • Founded January 2013
  • Employees 3
  • Website

Company Summary

Woodland is a biopharma services firm (CRO) that offers drug-resistant models for the development of oncology drugs. Discovery teams at oncology therapy makers will use our modeling services to better profile preclinical candidates. Drug resistance is important because it is what kills people. Naive tumors are often well addressed with surgery and first-line standard of care. But this distinction is not yet reflected in discovery strategies.


  • Default avatar
    Michael Briggs
    President and Founder

    Most recently Senior Director of Biology at Vertex. Previously at Pharmacia and Ligand.

  • Default avatar
    Raphael Nir

    Raphael is CEO of SBH Sciences in Natick, an in vitro CRO. Woodland is an extension of SBH's existing service lines.

  • Default avatar
    Carol Gebert
    Chief Business Officer

    Sales and marketing professional selling CRO services for 4 years, and other biopharma products for over 10 years.